Skip to main content

Advertisement

SpringerLink
Log in

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Pseudomyxoma peritonei (PMP) is the intra-peritoneal accumulation of mucus due to mucinous neoplasia, most often from a ruptured mucinous appendiceal neoplasm. A similar syndrome is caused by appendix cancer and other gastrointestinal malignancies. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provides long-term survival in selected patients with these conditions. The management of the appendiceal neoplasm prior to development of peritoneal involvement is initially discussed. This is followed by an overview of the management of peritoneal disease caused by appendiceal neoplasms. The principles and basic techniques of CRS and intraperitoneal chemotherapy (both intraoperative and post operative) are then discussed. Survival outcomes from several large studies are summarised. Prognostic factors are also discussed. We report our basic outcome data for the 345 patients with PMP or appendix cancer treated at our institution. Finally, the promising upcoming treatment of mucolytic therapy is discussed. We conclude that appendiceal neoplasms, although rare can cause significant morbidity and mortality. With optimal management long-term survival is possible in the majority of patients. The key to treatment is complete cytoreduction and use of hyperthermic intraperitoneal chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34:196–201

    Article  CAS  PubMed  Google Scholar 

  2. Sugarbaker PH (2009) Epithelial appendiceal neoplasms. Cancer J 15:225–235

    Article  PubMed  Google Scholar 

  3. Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69–76

    Article  PubMed  Google Scholar 

  4. Misdraji J (2015) Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei. Mod Pathol 28:S67–S79

    Article  PubMed  Google Scholar 

  5. Moran BJ, Cecil TD (2003) The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12:585–603

    Article  PubMed  Google Scholar 

  6. Esquivel J, Sugarbaker PH (2000) Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 87:1414–1418

    Article  CAS  PubMed  Google Scholar 

  7. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ (1997) Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 2:197–226

    CAS  PubMed  Google Scholar 

  8. Mukherjee A, Parvaiz A, Cecil TD, Moran BJ (2004) Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 25:411–414

    CAS  PubMed  Google Scholar 

  9. Ferreira CR, Carvalho JP, Soares FA, Siqueira SA, Carvalho FM (2008) Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer 18:59–65

    Article  CAS  PubMed  Google Scholar 

  10. Buell-Gutbrod R, Gwin K (2013) Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei. Am Soc Clin Oncol Educ Book 2013:221–225

    Article  Google Scholar 

  11. Varisco B, McAlvin B, Dias J, Franga D (2004) Adenocarcinoid of the appendix: is right hemicolectomy necessary? a meta-analysis of retrospective chart reviews. Am Surg 70:593–599

    PubMed  Google Scholar 

  12. Gonzalez-Moreno S, Sugarbaker PH (2004) Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Bri J Surg 91:304–311

    Article  CAS  Google Scholar 

  13. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27:1089–1103

    Article  PubMed  Google Scholar 

  14. Honore C, Caruso F, Dartigues P, et al. (2015) Strategies for preventing pseudomyxoma peritonei after resection of a mucinous neoplasm of the appendix. Anticancer Res 35:4943–4947

    PubMed  Google Scholar 

  15. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  CAS  PubMed  Google Scholar 

  16. Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B (2013) Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg 79:1171–1176

    PubMed  Google Scholar 

  17. Hinson FL, Ambrose NS (1998) Pseudomyxoma peritonei. Bri J Surg 85:1332–1339

    Article  CAS  Google Scholar 

  18. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A (1992) Pseudomyxoma peritonei of appendiceal origin: the memorial sloan-kettering cancer center experience. Cancer 70:396–401

    Article  CAS  PubMed  Google Scholar 

  19. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (1995) Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19:1390–1408

    Article  CAS  PubMed  Google Scholar 

  20. Ronnett BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH (1997) The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 21:1144–1155

    Article  CAS  PubMed  Google Scholar 

  21. Turaga KK, Pappas SG, Gamblin T (2012) Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol 19:1379–1385

    Article  PubMed  Google Scholar 

  22. Mahteme H, Sugarbaker PH (2004) Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Bri J Surg 91:1168–1173

    Article  CAS  Google Scholar 

  23. Randle RW, Griffith KF, Fino NF, et al. (2015) appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res 196:229–234

    Article  PubMed  Google Scholar 

  24. Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J (2009) Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma. Ann Surg Oncol 16:2765–2770

    Article  PubMed  Google Scholar 

  25. Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH (2004) Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87:162–166

    Article  PubMed  Google Scholar 

  26. Koh JL, Liauw W, Chua T, Morris DL (2013) Carbohydrate antigen 19–9 (ca 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol 4:173–181

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH (1995) abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–538

    CAS  PubMed  Google Scholar 

  28. Dineen SP, Royal RE, Hughes MS, et al. (2015) A simplified preoperative assessment predicts complete cytoreduction and outcomes in patients with low-grade mucinous adenocarcinoma of the appendix. Ann Surg Oncol 22:3640–3646

    Article  PubMed  PubMed Central  Google Scholar 

  29. Pfannenberg C, Konigsrainer I, Aschoff P, et al. (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 16:1295–1303

    Article  PubMed  Google Scholar 

  30. Low RN, Barone RM, Lucero J (2015) Comparison of MRI and CT for predicting the peritoneal cancer index (pci) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708–1715

    Article  PubMed  Google Scholar 

  31. Elias D, Faron M, Goere D, et al. (2014) A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases. Ann Surg Oncol 21:2052–2058

    Article  PubMed  Google Scholar 

  32. Maggiori L, Goere D, Viana B, et al. (2013) Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? a case-control study. Ann Surg 258:116–121

    Article  PubMed  Google Scholar 

  33. de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA (2013) Cytoreductive surgery and hipec for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321–327

    Article  PubMed  Google Scholar 

  34. Allard MA, Adam R, Ruiz A, et al. (2013) Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively. Eur J Surg Oncol 39:981–987

    Article  CAS  PubMed  Google Scholar 

  35. Varban O, Levine EA, Stewart JH, McCoy TP, Shen P (2009) Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer 115:3427–3436

    Article  PubMed  Google Scholar 

  36. Kianmanesh R, Scaringi S, Sabate JM, et al. (2007) Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245:597–603

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chua TC, Yan TD, Zhao J, Morris DL (2009) Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol 35:1299–1305

    Article  CAS  PubMed  Google Scholar 

  38. Alzahrani N, Ung L, Valle SJ, Liauw W, Morris DL (2015) Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre. ANZ J Surg. 2015 Jul 14. doi:10.1111/ans.13231. [Epub ahead of print]

  39. Sugarbaker PH (2003) Peritonectomy procedures. Surg Oncol Clin N Am 12:703–727

    Article  PubMed  Google Scholar 

  40. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sugarbaker PH (1994) Dissection by electrocautery with a ball tip. J Surg Oncol 56:246–248

    Article  CAS  PubMed  Google Scholar 

  42. Sugarbaker PH (2010) Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol 101:251–252

    Article  PubMed  Google Scholar 

  43. Bijelic L, Sugarbaker PH (2008) Cytoreduction of the small bowel surfaces. J Surg Oncol 97:176–179

    Article  PubMed  Google Scholar 

  44. Vazquez Vde L, Sugarbaker PH (2003) Total anterior parietal peritonectomy. J Surg Oncol 83:261–263

    Article  PubMed  Google Scholar 

  45. Sugarbaker PH (2002) The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 28:443–446

    Article  CAS  PubMed  Google Scholar 

  46. Sugarbaker PH, Averbach AM (1996) Krukenberg syndrome as a natural manifestation of tumor cell entrapment. Cancer Treat Res 82:163–191

    Article  CAS  PubMed  Google Scholar 

  47. Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333

    Article  PubMed  Google Scholar 

  48. Chang-Yun L, Yonemura Y, Ishibashi H, et al. (2011) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in peritoneal carcinomatosis Gan To Kagaku Ryoho. Japanese J Cancer Chemother 38:2060–2064

    Google Scholar 

  49. Doud AN, Randle RW, Clark CJ, et al. (2015) Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 22:1645–1650

    Article  PubMed  Google Scholar 

  50. Turaga KK, Pappas S, Gamblin TC (2013) Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? Ann Surg Oncol 20:1063–1067

    Article  PubMed  Google Scholar 

  51. Gonzalez-Moreno S, Gonzalez-Bayon LA, Ortega-Perez G (2010) Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol 2:68–75

    Article  PubMed  PubMed Central  Google Scholar 

  52. van Ruth S, Verwaal VJ, Hart AA, van Slooten GW, Zoetmulder FA (2003) Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. Anticancer Res 23:1501–1508

    PubMed  Google Scholar 

  53. Fujimoto S, Takahashi M, Kobayashi K, et al. (1992) Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin c for patients with gastric cancer with peritoneal metastasis. Cancer 70:2754–2760

    Article  CAS  PubMed  Google Scholar 

  54. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA (2001) Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Bri J Surg 88:458–463

    Article  CAS  Google Scholar 

  55. Clavien PA, Barkun J, de Oliveira ML, et al. (2009) The clavien-dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196

    Article  PubMed  Google Scholar 

  56. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  57. Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? a systematic review of morbidity and mortality. Ann Surg 249:900–907

    Article  PubMed  Google Scholar 

  58. Yang TX, Morris DL, Chua TC (2013) Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 56:519–531

    Article  PubMed  Google Scholar 

  59. Sugarbaker PH, Alderman R, Edwards G, et al. (2006) Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13:635–644

    Article  PubMed  Google Scholar 

  60. Chua TC, Moran BJ, Sugarbaker PH, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456

    Article  PubMed  Google Scholar 

  61. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2011) Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum 54:293–299

    Article  PubMed  Google Scholar 

  62. Elias D, Glehen O, Pocard M, et al. (2010) A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg 251:896–901

    Article  PubMed  Google Scholar 

  63. Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL (2015) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. ANZ J Surg 2015 Jul 14. doi:10.1111/ans.13152. [Epub ahead of print]

  64. Yan TD, Bijelic L, Sugarbaker PH (2007) Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 14:2289–2299

    Article  PubMed  Google Scholar 

  65. Polanco PM, Ding Y, Knox JM, et al. (2015) institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol 22:1673–1679

    Article  PubMed  Google Scholar 

  66. Andreasson H, Lorant T, Pahlman L, Graf W, Mahteme H (2014) cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve. Eur J Surg Oncol 40:930–936

    Article  CAS  PubMed  Google Scholar 

  67. Kusamura S, Baratti D, Virzi S, et al. (2013) Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. J Surg Oncol 107:312–319

    Article  PubMed  Google Scholar 

  68. Rowan AD, Buttle DJ, Barrett AJ (1990) The cysteine proteinases of the pineapple plant. Biochem J 266:869–875

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Manov I, Hirsh M, Iancu TC (2002) Acetaminophen hepatotoxicity and mechanisms of its protection by n-acetylcysteine: a study of hep3b cells. Exp Toxicol Pathol 53:489–500

    Article  CAS  PubMed  Google Scholar 

  70. Turner J, Jones CE (2009) Regulation of mucin expression in respiratory diseases. Biochem Soc Trans 37:877–881

    Article  CAS  PubMed  Google Scholar 

  71. Akhter J, Pillai K, Chua TC, Alzarin N, Morris DL (2014) Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters. American J Cancer Res 4:495–507

    Google Scholar 

  72. Pillai K, Akhter J, Chua TC, Morris DL (2014) A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei. Int J Cancer 134:478–486

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of New South Wales, Sydney, New South Wales

    Joshua Lansom, Nayef Alzahrani & David L. Morris

  2. Department of Surgical Oncology, St George Hospital, Sydney, NSW, Australia

    Joshua Lansom, Nayef Alzahrani, Winston Liauw & David L. Morris

  3. Cancer Care Centre, St George Hospital, Sydney, NSW, Australia

    Winston Liauw

Authors
  1. Joshua Lansom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nayef Alzahrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Winston Liauw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David L. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joshua Lansom.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lansom, J., Alzahrani, N., Liauw, W. et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. Indian J Surg Oncol 7, 166–176 (2016). https://doi.org/10.1007/s13193-015-0478-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-015-0478-9

Keywords

Search

Navigation